Live Breaking News & Updates on ஜேசன் அட்கின்சன்|Page 7

Stay updated with breaking news from ஜேசன் அட்கின்சன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Mindset Pharma Inc.: Mindset Pharma Announces Closing of Non-Brokered Private Placement, Increasing Aggregate Gross Proceeds Raised to $5,000,000


Mindset Pharma Inc.: Mindset Pharma Announces Closing of Non-Brokered Private Placement, Increasing Aggregate Gross Proceeds Raised to $5,000,000
Mindset or the
Company ), a drug discovery and development company focused on developing next generation psychedelic medicines for the treatment of neuropsychiatric and neurological indications with unmet needs, is pleased to announce that it has closed an additional non-brokered private placement, pursuant to which the Company issued an aggregate of 2,021,187 units (a
Unit ) of the Company at a price of $0.40 per Unit (the
Offering Price ) for aggregate gross proceeds of $808,475 (the
Offering ). Inclusive of the brokered private placement that was completed by the Company on December 15, 2020, the Company has issued an aggregate of 12,500,000 Units for total gross proceeds of $5,000,000. ....

United States , Kostenloser Wertpapierhandel , Jason Atkinson , James Lanthier , Unit Of The Company , Newsfile Corp , Company On , Corporate Development , Mindset Pharma Inc , Company Management Discussion , Canadian Securities Exchange , Common Share , Chief Executive Officer , Common Shares , Multilateral Instrument , Minority Security Holders , Special Transactions , United States Securities Act , ஒன்றுபட்டது மாநிலங்களில் , ஜேசன் அட்கின்சன் , அலகு ஆஃப் தி நிறுவனம் , நிறுவனம் ஆன் , பெருநிறுவன வளர்ச்சி , மனநிலை பார்மா இன்க் , நிறுவனம் மேலாண்மை கலந்துரையாடல் , கனடியன் பத்திரங்கள் பரிமாற்றம் ,

Mindset Pharma Inc.: Mindset Pharma Announces Upsizing and Closing of $4.17 Million Brokered Private Placement Financing


Mindset Pharma Inc.: Mindset Pharma Announces Upsizing and Closing of $4.17 Million Brokered Private Placement Financing
Mindset or the
Company ), a drug discovery and development company focused on developing next generation psychedelic medicines for the treatment of neuropsychiatric and neurological indications with unmet needs, is pleased to announce that it has upsized and completed its previously announced brokered private placement, led by Mackie Research Capital Corporation, as sole agent and sole bookrunner (the
Agent ), pursuant to which the Company issued an aggregate of 10,428,813 units (a
Unit ) of the Company at a price of $0.40 per Unit (the
Offering Price ) for aggregate gross proceeds of $4,171,525.20, including the full exercise of the over-allotment option (the ....

United States , Kostenloser Wertpapierhandel , Jason Atkinson , James Lanthier , Mackie Research Capital Corporation , Unit Of The Company , Newsfile Corp , Corporate Development , Mindset Pharma Inc , Company Management Discussion , Canadian Securities Exchange , Common Share , Common Shares , Each Broker Warrant , Offering Price , Multilateral Instrument , Minority Security Holders , Special Transactions , United States Securities Act , ஒன்றுபட்டது மாநிலங்களில் , ஜேசன் அட்கின்சன் , மேக்கி ஆராய்ச்சி மூலதனம் நிறுவனம் , அலகு ஆஃப் தி நிறுவனம் , பெருநிறுவன வளர்ச்சி , மனநிலை பார்மா இன்க் , நிறுவனம் மேலாண்மை கலந்துரையாடல் ,